Dare Bioscience, Inc.
Ticker: 1401914
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 0.15 | 0.00-100.0% | 0.03-25.0% | 0.04+100.0% | 0.02+0.0% | 0.02+100.0% | 0.01-99.0% | 1.00 |
| Total Income | 0.15 | 0.00-100.0% | 0.03-25.0% | 0.04+100.0% | 0.02+0.0% | 0.02+100.0% | 0.01-99.0% | 1.00 |
| EXPENSES | ||||||||
| Expenditure | 3.15-14.2% | 3.67-20.4% | 4.61-2.3% | 4.72-36.0% | 7.38+0.0% | 7.38+22.4% | 6.03-35.9% | 9.40 |
| PROFIT | ||||||||
| Net Profit | -3.00+15.7% | -3.56+18.7% | -4.38+6.8% | -4.70-136.4% | 12.91+0.0% | 12.91+291.0% | -6.76+18.6% | -8.30 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00%-200.00pp | 100.00% | 100.00%+200.00pp | -100.00% | -100.00% |
| EPS | -0.21+25.0% | -0.28+44.0% | -0.50+9.1% | -0.55-135.9% | 1.53+0.0% | 1.53+2285.7% | -0.07+22.2% | -0.09 |
Corporate Events
Board MeetingDARE
202611Jun
Board Meeting
Annual meeting of stockholders to elect Class III directors,…
SEC Filing ↗ Board MeetingDARE
202617Apr
Board Meeting
Gregory W. Matz resigned as a Class III director, and anothe…
SEC Filing ↗